Y-Intercept (HK)
HELP

Y-Intercept (HK)’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Y-Intercept (HK)’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.21M Buy
+424,276
New +$4.43M 0.12% 221

Other funds holding HELP

WIM
WealthPlan Investment Management Omaha, Nebraska $2.07B AUM 21.2% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
KTC
Kentucky Trust Company Danville, Kentucky $200M AUM 22.53% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return
NL
NVWM LLC Yardley, Pennsylvania $533M AUM 27.53% 1-Year Est. Return
CoreCap Advisors
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Y-Intercept (HK)'s HELP Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Helus Pharma Inc. Common Stock (HELP) in Q3 2026: 424,276 shares worth $5.21M. The stake represents 0.12% of the portfolio and ranks #221 among its holdings.

8 funds tracked by Wall St. Rank hold HELP as of Q3 2026.

  • Y-Intercept (HK) held 424,276 shares of Helus Pharma Inc. Common Stock worth $5.21M as of Q3 2026.
  • Helus Pharma Inc. Common Stock was a new Y-Intercept (HK) position in Q3 2026.
  • Helus Pharma Inc. Common Stock made up 0.12% of Y-Intercept (HK)'s portfolio in Q3 2026, its #221 holding.
  • 8 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.